Results 81 to 90 of about 49,304 (230)

Prevention of cervical intraepithelial neoplasia and cervical cancer [PDF]

The American Journal of Clinical Nutrition, 1995
We review the current status of prevention trials in the management of cervical intraepithelial neoplasia (CIN) and cervical cancer. Two large, randomized controlled trials have shown that folic acid is inactive in reversing low to moderate grade CIN.
Meyskens, F L, Jr, Manetta, A
openaire   +5 more sources

Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate [PDF]

, 2009
Introduction Methods Results Discussion Conclusion Abstract Consistent evidence underlines the utility of human papillomavirus (HPV) DNA testing in the management of women with equivocal cervical cytological abnormalities, but not in case of low-grade ...
ALTS group, Anonymous, Andersson, Arbyn, Arbyn, Arbyn, Arbyn, Arbyn, Arbyn, Arbyn, Arias-Pulido, ASCUS-LSIL Triage Study Group, ASCUS-LSIL Triage Study Group, Bais, Bergeron, Bergeron, Berkhof, Bibbo, Boardman, Bradburn, Bruner, Carozzi, Castle, Clifford, Cochran, Coleman, Cuschieri, Cuzick, Dalla Palma, Depuydt, Dersimonian, Dudding, European Commission, Evans, Ferris, Franceschi, Giovannelli, Guido, Guyot, Harris, Higgins, Holowaty, Jordan, Kadish, Kelly, Kendall, Kiatpongsan, Ko, Ko, Kulasingam, Kurman, Kyrgiou, Lau, Lee, Legood, Light, Lin, Llewellyn, Lonky, Luff, Lytwyn, Manos, McNutt, Melnikow, Molden, Monsonego, Morin, Moss, Nieh, Pretorius, Rebello, Ronco, Rowe, Sasieni, Sawaya, Schiffman, Schiffman, Selvaggi, Sharp, Sharp, Sherman, Shlay, Solomon, Solomon, Solomon, Sutton, Thompson, Tsoumpou, von Knebel, Wensveen, Wentzensen, Wright, Wright, Wright, Wright, You, Zhang, Zielinski, zur Hausen   +97 more
core   +1 more source

Real‐world evaluation of a population‐based vaginal self‐sampling program for cervical cancer prevention in Region Skåne, Sweden

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Large‐scale HPV self‐sampling screening distributed 557 976 kits, resulting in 208 386 returned samples with 98% validity. HPV positivity was detected in 19% of participants, leading to clinical follow‐up. Biopsy confirmed 980 high‐grade cervical lesions and 32 cervical cancers.
Caroline Hellsten, Ola Forslund, Christer Borgfeldt   +2 more
wiley   +1 more source

Expression of the stem cell markers NANOG and SOX2 in the cervical squamous carcinogenesis

Radiology and Oncology
The aim of the present study was to assess a diagnostic potential of stem cell markers NANOG and SOX2 for classifying cervical squamous intraepithelial lesions (SILs)/cervical intraepithelial neoplasia (CIN).
Koren Miha, Zlajpah Margareta, Poljak Mario, Komlos Kristina Fujs, Flezar Margareta Strojan   +4 more
doaj   +1 more source

HPV42 – a human papillomavirus classified as a low‐risk type with oncogenic potential

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Human papillomavirus (HPV) type 42 is a rare HPV type currently classified as “low‐risk” and belongs to the alpha genus. It has primarily been detected in benign vulvar papillomas and is predominantly associated with benign lesions such as anogenital warts.
Sven Niklas Burmann, Ulrike Wieland, Steffi Silling, Frank Oellig, David Chromy, Julia Hyun, Thilo Gambichler, Alexander Kreuter   +7 more
wiley   +1 more source

Clinical analysis of cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia

Medicine, 2017
The purpose of this prospective cohort study is to evaluate the importance of screening and its diagnostic accuracy compared with the pathological diagnosis of cervical intraepithelial neoplasia (CIN) with vaginal intraepithelial neoplasia (VAIN).The prospective study enrolled 419 patients (pts) and was conducted between February 1, 2015 and January 31,
He, Yue, Zhao, Qun, Geng, Yu-Ning, Yang, Shu-Li, Yin, Cheng-Hong, Wu, Yu-Mei   +5 more
openaire   +2 more sources

Cost‐effectiveness analysis of human papillomavirus (HPV) genotyping strategies for management of HPV‐positive women in cervical cancer screening

International Journal of Cancer, Volume 158, Issue 12, Page 3141-3151, 15 June 2026.
What's new? Persistent infection with high‐risk human papillomavirus (HPV) causes most invasive cervical cancer cases, leading many countries to transition from cytology to primary HPV‐based screening. Despite the benefits, HPV‐based screening may also lead to unnecessary procedures, psychological burden, and strain on healthcare systems.
Kelsi R. Kroon, Johannes A. Bogaards, Johannes Berkhof   +2 more
wiley   +1 more source

Health care policy trial of primary human papillomavirus–based cervical screening in Denmark: Comparison of three triage algorithms

International Journal of Cancer, Volume 158, Issue 12, Page 3197-3207, 15 June 2026.
What's new? Primary human papillomavirus (HPV)–based screening has shown superiority to cytology‐based screening in reducing cervical cancer risk in clinical trials. However, the benefit must be balanced with potential overdiagnosis/overtreatment.
Jeppe Bennekou Schroll, Jesper Bonde, Elsebeth Lynge, Marianne Waldstrøm, Petra Hall Viborg, Anna Frandsen, Rikke Holst Andersen, Susanne Merete Nielsen, Bettina Kjær Kristensen, Doris Schledermann, Berit Andersen, on behalf ofthe National Danish Cervical Cancer Screening Steering Committee   +11 more
wiley   +1 more source

Cervical Intraepithelial Neoplasia, Cervical Cancer, and HPV [PDF]

Annual Review of Public Health, 1996
Major progress has been made to control cervical cancer in the United States and Europe using screening programs, although it remains a major cause of morbidity and mortality in the developing world. The association between cervical cancer and a sexually transmissible etiologic agent was hypothesized long before identification of human ...
openaire   +2 more sources

The costs of accessible quality assured syphilis diagnostics: informing quality systems for rapid syphilis tests in a Tanzanian setting. [PDF]

, 2013
OBJECTIVES: To determine the costs of Rapid Syphilis Test (RSTs) as compared with rapid plasma reagin (RPR) when implemented in a Tanzanian setting, and to determine the relative impact of a quality assurance (QA) system on the cost of RST implementation.
Changalucha, John, Kelly, Helen, Mosha, Jacklin F, Peeling, Rosanna W, Sollis, Kimberly A, Sweeney, Sedona, Terris-Prestholt, Fern   +6 more
core   +1 more source